Anti-VEGF Treatment Strategies for Wet AMD

Anti-VEGF Treatment Strategies for Wet AMD

Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2012/786870
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis
by: Datseris I, et al.
Published: (2025-01-01)

Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
by: Xiaobei Yin, et al.
Published: (2022-01-01)

Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
by: Agnieszka Nowosielska, et al.
Published: (2024-03-01)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
by: Deli Krizova, et al.
Published: (2014-01-01)

Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
by: Ermete Giancipoli, et al.
Published: (2018-01-01)

Extensive Macular Atrophy with Pseudodrusen Imaged with OCT Angiography
by: Jaclyn L. Kovach
Published: (2018-01-01)

Use of Anti-VEGF Agents in Glaucoma Surgery
by: Mark Slabaugh, et al.
Published: (2017-01-01)

Anti-VEGF Cancer Therapy in Nephrology Practice
by: Hassan Izzedine
Published: (2014-01-01)

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
by: Pedro Neves Cardoso, et al.
Published: (2017-01-01)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)

A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy
by: Robert Hodgson, et al.
Published: (2025-01-01)

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01)

Human Platelets Take up Anti-VEGF Agents
by: B. Sobolewska, et al.
Published: (2021-01-01)

Anti-VEGF in a Marathon Runner’s Retinopathy Case
by: Alexander Kahjun Soon, et al.
Published: (2016-01-01)

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
by: Caroline Hilmi, et al.
Published: (2012-01-01)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
by: P. ET. Lau, et al.
Published: (2018-01-01)

Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
by: Pearse A. Keane, et al.
Published: (2012-01-01)

Central Serous Chorioretinopathy: Multimodal Imaging and Management Options
by: Prashanth G. Iyer, et al.
Published: (2020-01-01)

Systems Biology Profiling of AMD on the Basis of Gene Expression
by: Mones S. Abu-Asab, et al.
Published: (2013-01-01)

Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells
by: Raffaele Nuzzi, et al.
Published: (2012-01-01)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
by: Laura N. Distefano, et al.
Published: (2017-01-01)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
by: Ana Catarina Pedrosa, et al.
Published: (2017-01-01)

Predictive Factors in OCT Analysis for Visual Outcome in Exudative AMD
by: Maria-Andreea Gamulescu, et al.
Published: (2012-01-01)

Prediction of OCT contours of short-term response to anti-VEGF treatment for diabetic macular edema using generative adversarial networks
by: Xueying Yang, et al.
Published: (2025-04-01)

Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions
by: Ernest V. Boiko, et al.
Published: (2017-01-01)

Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01)

The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury
by: Xiao Zhao, et al.
Published: (2021-01-01)

Combined Tractional and Rhegmatogenous Retinal Detachment in Proliferative Diabetic Retinopathy in the Anti-VEGF Era
by: Ya-Jui Hsu, et al.
Published: (2014-01-01)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)

Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?
by: Jacob W. Bruinius, et al.
Published: (2019-01-01)

Dry eye disease treatment improves subjective quality-of-life responses in patients with AMD, independent of disease stage.
by: Nehal Nailesh Mehta, et al.
Published: (2025-01-01)

Visual, Musculoskeletal, and Balance Complaints in AMD: A Follow-Up Study
by: Christina Zetterlund, et al.
Published: (2016-01-01)

Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
by: Sasikumar Jalajakumari Soumya, et al.
Published: (2024-09-01)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
by: Ying Zhang, et al.
Published: (2022-01-01)

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
by: Sónia Torres-Costa, et al.
Published: (2022-01-01)

Optical Coherence Tomography Angiography of Combined Central Retinal Artery and Vein Occlusion
by: Shuo-chieh Wu, et al.
Published: (2018-01-01)

Fault Diagnosis of Rotating Machinery Based on Adaptive Stochastic Resonance and AMD-EEMD
by: Peiming Shi, et al.
Published: (2016-01-01)

Rat Hippocampal Neural Stem Cell Modulation Using PDGF, VEGF, PDGF/VEGF, and BDNF
by: Neus Gomila Pelegri, et al.
Published: (2019-01-01)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
by: Selwyn M. Prea, et al.
Published: (2015-01-01)

The Combined Application of Surface Floating Wetlands and Bottom Anaerobic to Remediate AMD-Contaminated Lakes
by: Tianling Fu, et al.
Published: (2022-01-01)